1. Prognostic impact of invariant natural killer T cells in solid and hematological tumors; systematic review and meta-analysis.
- Author
-
Alhamawi, Renad M., Aloufi, Noof, Alamri, Abeer F., Altubayli, Fatima A., Alsairi, Raghad T., Alhamad, Reem A., Alharbi, Shouq M., Ankhli, Zainab A., Eid, Hamza M. A., and Almutawif, Yahya A.
- Subjects
- *
CYTOTOXIC T cells , *PROGRESSION-free survival , *KILLER cells , *SCIENCE databases , *OVERALL survival - Abstract
BACKGROUND: Invariant natural killer T (iNKT) cells are an immune subset that purportedly link the adaptive and the innate arms of the immune system. Importantly, iNKT cells contribute to anti-cancer immunity in different types of hematological and solid malignancies by secreting pro-inflammatory cytokines. Therefore, using such cells in treating different type of tumors would be an ideal candidate for cancer immunotherapy. OBJECTIVE: To assess the prognostic effect of iNKT cells across different types of solid and hematological tumors. METHODS: In systematic review and meta-analysis, articles assessed the prognostic effect of iNKT cells were systemically searched using the scientific databases including Google Scholar, ScienceDirect, PubMed, Cochrane Central, and Scopus. RESULTS: Strikingly, the analysis showed the positive impact of intratumoral or circulating iNKT cells on the survival rate in patients with all studied tumors with overall effect of a pooled hazard ratio of 0.89 (95% CI 0.81 to 0.98; p = 0.01). A highly statistical heterogeneity was noted between studied tumor with I2 = 87%; p = 0.00001. CONCLUSIONS: Taken together, this study would present a new insight into the impact of iNKT cells correlate with caner patients' survival rate and how such cells would be used as a therapeutic target in these patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF